OncoPharm
OncoPharm
John Bossaer
Lorlatinib
24 minutes Posted Nov 6, 2018 at 6:24 pm.
0:00
24:13
Download MP3
Show notes
Reviewing the latest TKI approved for ALK rearranged metastatic NSCLC. And hey, how 'bout that crazy rifampin hepatotoxicity interaction?